Qinting Dong , Yuhang Luo , Yan Pan , Yi Liu , Liangshan Qin , Kang Ouyang , Ying Chen , Zuzhang Wei , Yifeng Qin , Weijian Huang
{"title":"The C-terminal nsP1a protein of porcine astrovirus antagonizes interferon beta production by targets MAVS and IRF3 signaling","authors":"Qinting Dong , Yuhang Luo , Yan Pan , Yi Liu , Liangshan Qin , Kang Ouyang , Ying Chen , Zuzhang Wei , Yifeng Qin , Weijian Huang","doi":"10.1016/j.vetmic.2025.110530","DOIUrl":null,"url":null,"abstract":"<div><div>Astroviruses (AstV) are positive-sense, single-stranded RNA viruses that can infect humans and a broad spectrum of mammalian and avian species. Recently, Astrovirus strains from various hosts have been implicated in extra-intestinal infections, leading to symptoms such as encephalitis, meningitis, hepatitis, nephropathy and gout. These findings highlight the significant risks associated with its pathogenicity and its potential for interspecies transmission. The astrovirus nsP1a polyprotein is known to produce at least four distinct products. However, the precise demarcation of boundaries for these proteins remains unclear yet. Interferons, along with their antiviral immune responses, have important roles during early stages of viral infection. Viruses typically employ their encoded proteins to evade host-generated immune responses during infections through different mechanisms. In this study, we identified nonstructural proteins of PAstV1 that hinder the type I interferon (IFN) pathway. This was achieved using an IFN-β promoter reporter and by analyzing IFN-β mRNA levels in HEK 293 T cells. Our findings indicate that PAstV1 nsP1a/4 inhibits IFN-β promoter activation mediated via components in the RIG-I-like receptor (RLR) signaling pathway, specifically RIG-I, MDA5, MAVS, and IRF3. Further analyses revealed that PAstV1 nsP1a/4 protein interacts with MAVS and IRF3 to impede the RIG-I/MDA5 signaling and affects their ability to induce IFN. Overall, our results demonstrate that the ectopic expression of PAstV1 nsP1a/4 antagonizes IFN-β production by interacts with MAVS and IRF3. This reveals a novel mechanism by which PAstV nonstructural proteins evade the host’s innate antiviral immune response.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"305 ","pages":"Article 110530"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525001658","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Astroviruses (AstV) are positive-sense, single-stranded RNA viruses that can infect humans and a broad spectrum of mammalian and avian species. Recently, Astrovirus strains from various hosts have been implicated in extra-intestinal infections, leading to symptoms such as encephalitis, meningitis, hepatitis, nephropathy and gout. These findings highlight the significant risks associated with its pathogenicity and its potential for interspecies transmission. The astrovirus nsP1a polyprotein is known to produce at least four distinct products. However, the precise demarcation of boundaries for these proteins remains unclear yet. Interferons, along with their antiviral immune responses, have important roles during early stages of viral infection. Viruses typically employ their encoded proteins to evade host-generated immune responses during infections through different mechanisms. In this study, we identified nonstructural proteins of PAstV1 that hinder the type I interferon (IFN) pathway. This was achieved using an IFN-β promoter reporter and by analyzing IFN-β mRNA levels in HEK 293 T cells. Our findings indicate that PAstV1 nsP1a/4 inhibits IFN-β promoter activation mediated via components in the RIG-I-like receptor (RLR) signaling pathway, specifically RIG-I, MDA5, MAVS, and IRF3. Further analyses revealed that PAstV1 nsP1a/4 protein interacts with MAVS and IRF3 to impede the RIG-I/MDA5 signaling and affects their ability to induce IFN. Overall, our results demonstrate that the ectopic expression of PAstV1 nsP1a/4 antagonizes IFN-β production by interacts with MAVS and IRF3. This reveals a novel mechanism by which PAstV nonstructural proteins evade the host’s innate antiviral immune response.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.